Generation Historical Cash Flow
| GBIO Stock | USD 1.43 0.01 0.69% |
Analysis of Generation Bio cash flow over time is an excellent tool to project Generation Bio future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 106 M or Depreciation of 3.8 M as it is a great indicator of Generation Bio ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Generation Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Generation Bio is a good buy for the upcoming year.
Generation |
About Generation Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Generation balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Generation's non-liquid assets can be easily converted into cash.
Generation Bio Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Generation Bio to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Generation Bio operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Generation Bio's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Generation Bio current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. At this time, Generation Bio's Cash Flows Other Operating is very stable compared to the past year.
Generation Bio cash flow statement Correlations
Click cells to compare fundamentals
Generation Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Generation Bio cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | 100K | 323.1M | 214.7M | (581K) | (565K) | (536.8K) | |
| Investments | 67.9M | (199.7M) | 198.9M | (192.5M) | (9.7M) | (10.2M) | |
| Change In Cash | 7.7M | 47.8M | 315.9M | (282.0M) | (26.6M) | (25.3M) | |
| Stock Based Compensation | 4.2M | 8.4M | 17.9M | 24.5M | 24.3M | 15.2M | |
| Free Cash Flow | (60.3M) | (75.7M) | (97.8M) | (111.2M) | (60.1M) | (63.1M) | |
| Change In Working Capital | 15.2M | (1.7M) | 4.2M | 1.0M | 53.5M | 56.2M | |
| Begin Period Cash Flow | 9.5M | 17.2M | 64.9M | 380.8M | 98.9M | 106.0M | |
| Total Cashflows From Investing Activities | 48.0M | (205.2M) | 193.0M | (192.5M) | (173.3M) | (164.6M) | |
| Other Cashflows From Financing Activities | (22K) | 109.2M | 2.8M | 629K | (183K) | (173.9K) | |
| Depreciation | 1.9M | 3.4M | 4.5M | 5.1M | 5.3M | 3.8M | |
| Other Non Cash Items | (317K) | 249K | 766K | 3.6M | (9.3M) | (8.8M) | |
| Capital Expenditures | 20.0M | 5.5M | 6.0M | 8.8M | 7.4M | 6.8M | |
| Total Cash From Operating Activities | (40.3M) | (70.1M) | (91.8M) | (102.4M) | (52.7M) | (55.4M) | |
| Change To Operating Activities | 14.5M | (268K) | 2.4M | 2.4M | 2.2M | 3.8M | |
| Issuance Of Capital Stock | 109.0M | 322.8M | 211.9M | 12.4M | 36M | 34.2M | |
| Net Income | (61.3M) | (80.5M) | (119.2M) | (136.6M) | (126.6M) | (132.9M) | |
| Total Cash From Financing Activities | 78K | 323.1M | 214.7M | 13.0M | 35.8M | 34.0M | |
| End Period Cash Flow | 17.2M | 64.9M | 380.8M | 98.9M | 72.2M | 118.0M | |
| Change To Netincome | 3.9M | 8.7M | 18.1M | 30.3M | 34.8M | 36.6M | |
| Change To Liabilities | 761K | (1.4M) | 3.6M | (591K) | (679.7K) | (645.7K) |
Pair Trading with Generation Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Generation Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Generation Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Generation Stock
| 0.74 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.78 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
Moving against Generation Stock
| 0.8 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.68 | NAMS | NewAmsterdam Pharma | PairCorr |
| 0.36 | ESLAW | Estrella Immunopharma | PairCorr |
| 0.35 | MNOV | MediciNova | PairCorr |
| 0.33 | PHVS | Pharvaris BV | PairCorr |
The ability to find closely correlated positions to Generation Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Generation Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Generation Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Generation Bio Co to buy it.
The correlation of Generation Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Generation Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Generation Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Generation Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.17) | Revenue Per Share 0.28 | Quarterly Revenue Growth 2.52 | Return On Assets (0.19) | Return On Equity (0.86) |
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.